Risk Perceptions of Low Nicotine Cigarettes and Alternative Nicotine Products across Priority Smoking Populations

Rachel L. Denlinger-Apte, Lauren R. Pacek, Jennifer Cornacchione Ross, Maansi Bansal-Travers, Eric C. Donny, Dorothy K. Hatsukami and Dana Mowls Carroll
Additional contact information
Rachel L. Denlinger-Apte: Department of Social Sciences and Health Policy, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA
Lauren R. Pacek: Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC 27705, USA
Jennifer Cornacchione Ross: Department of Social Sciences and Health Policy, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA
Maansi Bansal-Travers: Roswell Park Comprehensive Cancer Center, Department of Health Behavior, Buffalo, NY 14263, USA
Eric C. Donny: Department of Physiology and Pharmacology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA
Dorothy K. Hatsukami: Department of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis, MN 55414, USA
Dana Mowls Carroll: Division of Environmental Health Sciences, School of Public Health, University of Minnesota, Minneapolis, MN 55414, USA

IJERPH, 2021, vol. 18, issue 10, 1-22

Abstract: Background: As the U.S. Food and Drug Administration considers a low nicotine product standard for cigarettes, it is important to examine how people who smoke, especially individuals from priority populations disproportionately affected by smoking, perceive low nicotine content (LNC) cigarettes and their relative risk perceptions of alternative nicotine delivery system (ANDS) products, including e-cigarettes and snus, and medicinal nicotine. Methods: Data are from Wave 4 (2016–2017) of the adult Population Assessment of Tobacco Use and Health (PATH) Study. We examined respondents’ absolute risk perceptions about nicotine, LNC cigarettes, ANDS products and medicinal nicotine; their relative risk perceptions of LNC cigarettes and ANDS products compared to conventional cigarettes; and their relative risk perceptions of medicinal nicotine compared to ANDS products. Results: The majority of respondents across priority smoking populations indicated snus, e-cigarettes, and LNC cigarettes were ‘about the same’ level of harmfulness or addictiveness as conventional cigarettes. The majority of respondents indicated e-cigarettes to be ‘about the same’ harmfulness as medicinal nicotine. Conclusions: Our study indicates that adults who smoke cigarettes generally have misperceptions about the harms of nicotine and the relative risks of ANDS products and such misperceptions exist regardless of their racial/ethnic identity, sexual orientation, and gender identity.

Keywords: nicotine; low nicotine cigarettes; e-cigarettes; snus; risk perceptions; race; ethnicity; LGBTQ+ (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2021
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/18/10/5311/pdf (application/pdf)
https://www.mdpi.com/1660-4601/18/10/5311/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:18:y:2021:i:10:p:5311-:d:556020

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().